Home     |     Advance Access   |     Open Access Papers   |   Editor's Choice   |   Archive   |    Symposium   |    Contact Us
QUICK SEARCH
Author Keyword Year Vol Page
[Search by Pubmed] [Search by Google]
Archive
BROWSE BY TOPIC

BROWSE BY YEAR
VOLUME 10 ISSUE 4 (Aug, 2018)

Editorial
Original Article
Mary Ellen Molloy , Monika Lewinska, Amanda K. Williamson, Thanh Thao Nguyen,Gamze Kuser-Abali, Lu Gong, Jiawei Yan, John B. Little, Pier Paolo Pandolfi,and Zhi-Min Yuan
Yang Yang ,Wei Huang,Rongfang Qiu, Ruiqiong Liu, Yi Zeng, Jie Gao, Yu Zheng, Yongqiang Hou, Shuang Wang, Wenqian Yu, Shuai Leng, Dandan Feng, and Yan Wang
Sanhong Liu, Zifeng Wang, Zukai Liu, Shuo Shi, Zhaoran Zhang, Jiawei Zhang,and Haifan Lin
Wei Zhao , Qingyuan Zhu, Peng Tan, Adebusola Ajibade, Teng Long, Wenyong Long, Qingtian Li, Pinghua Liu, Bo Ning, Helen Y. Wang, and Rong-Fu Wang
Enas R. Abu-Zhayia, Samah W. Awwad, Bella M. Ben-Oz, Hanan Khoury-Haddad, and Nabieh Ayoub*
Research Highlight
Yuan Meng, Hongzhi Li, Changwei Liu, Li Zheng, and Binghui Shen
  New Players in Cancer


Cover legend
In triple-negative breast cancer (TNBC) cells, miR-221/222 negatively regulate the expression of several suppressive components of the Wnt signaling pathway, such as WIF1, DKK2, SFRP2, and AXIN2, leading to the activation of ß-catenin. The activated ß-catenin then promotes the transcription of signature genes important for cell growth and migration, resulting in robust proliferation and metastasis of these cancer cells. See pages 302–315 by Liu et al. for details.
 
Copyright © 2011-2018 by Journal of Molecular Cell Biology All rights reserved
Shanghai ICP #05033115